Ingrid Torjesen' s stories
Sort by: Newest first Oldest first A-Z Z-A
-
Minister attempts to reassure science sector about life post-Brexit
The UK needs to improve at building business and innovating on the back of its own scientific discoveries, says Jo Johnson, Conservative Party MP and minister for universities and science.
-
Doctor and pharmacist payments by pharma revealed in database
An online database of payments and benefits in kind made by the pharmaceutical industry to doctors, pharmacists and nurses was published for the first time on 30 June 2016, enabling the public to see how individual professionals are paid by the pharmaceutical industry.
-
Nurofen TV advertisement banned by advertising watchdog
The advertising watchdog has banned a TV advertisement for one of the UK’s biggest painkiller brands, Nurofen, because it falsely claims that the product could specifically target joint and back pain.
-
Research unravels how brain changes in Alzheimer’s linked to diabetes Subscription
An enzyme closely linked to brain changes in Alzheimer’s disease also seems to have a role in glucose control, according to a study published in Diabetologia.
-
GPhC will not investigate Boots over claims it put pharmacists under unacceptable workplace pressure
The General Pharmaceutical Council has decided not to investigate Boots over allegations that it placed unacceptable pressure on pharmacists to perform medicines use reviews.
-
FDA approves first buprenorphine implant for opioid dependence
The US Food and Drug Administration (FDA) has approved the first buprenorphine implant for the maintenance treatment of opioid dependence in adults, a treatment that is being hailed as “a game changer”.
-
First self-administered monthly injection for multiple sclerosis approved in the US
Zinbryta (daclizumab), the first once-monthly self-administered injection for multiple sclerosis (MS), has been approved by the US Food and Drug Administration.
-
PSNC, RPS and Pharmacy Voice to join forces and publish forward view for community pharmacy
Pharmacy bodies are working together to develop their own forward view as government rejects PSNC’s counterproposals to £170m cuts.
-
US FDA approves first PD-1/PD-L1 inhibitor for most common bladder cancer
The US Food and Drug Administration has approved the immunotherapy atezolizumab (Tecentriq) to treat urothelial carcinoma, the most common form of bladder cancer.
-
Government review says antibiotics should not be prescribed without rapid diagnostic test
Patients in developed countries should not be prescribed an antibiotic without first having a rapid diagnostic test to ensure the drug is appropriate and drug companies must be forced to do more to find new antibiotic drugs, the final report of the UK government’s Review on Antimicrobial Resistance (AMR) has recommended.
Show 10 per page20 per page50 per page
